These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24549483)

  • 21. Botulinum toxin for axillary hyperhidrosis.
    de Almeida AR; Montagner S
    Dermatol Clin; 2014 Oct; 32(4):495-504. PubMed ID: 25152343
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum beyond wrinkles.
    Heckmann M; Schaller M; Ceballos-Baumann A; Plewig G
    Dermatol Surg; 1997 Dec; 23(12):1221-2. PubMed ID: 9426674
    [No Abstract]   [Full Text] [Related]  

  • 23. [Botulinum toxin in focal hyperhidrosis. An update].
    Hosp C; Naumann MK; Hamm H
    Hautarzt; 2012 Jun; 63(6):469-76. PubMed ID: 22638981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum toxin for the correction of hyperkinetic facial lines.
    Goodman G
    Australas J Dermatol; 1998 Aug; 39(3):158-63. PubMed ID: 9737041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contraindications and complications with the use of botulinum toxin.
    Klein AW
    Clin Dermatol; 2004; 22(1):66-75. PubMed ID: 15158548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CT-Guided Chemical Thoracic Sympathectomy versus Botulinum Toxin Type A Injection for Palmar Hyperhidrosis.
    Yang H; Kang J; Zhang S; Peng K; Deng B; Cheng B
    Thorac Cardiovasc Surg; 2019 Aug; 67(5):402-406. PubMed ID: 30216949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK; Hamm H; Lowe NJ;
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic Effectiveness of Needle Injection Versus Needle-Free Jet Injector System for Botulinum Toxin Type A in Palmar Hyperhidrosis.
    Watanabe H; Ohshima Y; Watanabe D
    J Cutan Med Surg; 2023; 27(5):481-486. PubMed ID: 37537972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facial hyperhidrosis: best practice recommendations and special considerations.
    Glaser DA; Hebert AA; Pariser DM; Solish N
    Cutis; 2007 May; 79(5 Suppl):29-32. PubMed ID: 17596098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Botox and Dysport: is there a dose conversion ratio in dermatology and aesthetic medicine?
    Karsai S; Raulin C
    J Am Acad Dermatol; 2010 Feb; 62(2):346-7. PubMed ID: 20115956
    [No Abstract]   [Full Text] [Related]  

  • 32. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans.
    Ahn KY; Park MY; Park DH; Han DG
    Plast Reconstr Surg; 2000 Feb; 105(2):778-84. PubMed ID: 10697192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmar and axillary hyperhidrosis treated with botulinum toxin: one-year clinical follow-up.
    Naver H; Swartling C; Aquilonius SM
    Eur J Neurol; 2000 Jan; 7(1):55-62. PubMed ID: 10809915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.
    Lueangarun S; Sermsilp C; Tempark T
    Dermatol Surg; 2018 Aug; 44(8):1094-1101. PubMed ID: 29659406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficacy, side effects and patient satisfaction with wrist conduction block anaesthesia prior to the treatment of palmar hyperhidrosis with botulinum toxin type A].
    Siebert T; Sinkgraven R; Fuchslocher M; Rzany B
    J Dtsch Dermatol Ges; 2003 Nov; 1(11):876-83. PubMed ID: 16281578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of a 10-year follow-up study of botulinum toxin A therapy for primary axillary hyperhidrosis in Australia.
    Rosen R; Stewart T
    Intern Med J; 2018 Mar; 48(3):343-347. PubMed ID: 29512329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treated patients in survey: High satisfaction with botulinum toxin in palmar hyperhidrosis].
    Deebaj R; Emtestam L; Lundeberg L; Brandin Samuelsson K; Girnita A
    Lakartidningen; 2015 Jan; 112():. PubMed ID: 25625725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
    Carruthers JA; Lowe NJ; Menter MA; Gibson J; Nordquist M; Mordaunt J; Walker P; Eadie N;
    J Am Acad Dermatol; 2002 Jun; 46(6):840-9. PubMed ID: 12063480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Axillary hyperhidrosis, botulinium A toxin treatment: Review].
    Clerico C; Fernandez J; Camuzard O; Chignon-Sicard B; Ihrai T
    Ann Chir Plast Esthet; 2016 Feb; 61(1):60-4. PubMed ID: 25555435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.